Samsara BioCapital, LLC - SUTRO BIOPHARMA INC ownership

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 2 filers reported holding SUTRO BIOPHARMA INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Samsara BioCapital, LLC ownership history of SUTRO BIOPHARMA INC
ValueSharesWeighting
Q3 2023$5,814,259
-25.4%
1,675,5790.0%1.78%
+30.1%
Q2 2023$7,791,442
+0.6%
1,675,5790.0%1.37%
-14.5%
Q1 2023$7,741,175
-42.8%
1,675,5790.0%1.60%
-45.1%
Q4 2022$13,538,678
+45.6%
1,675,5790.0%2.91%
+34.4%
Q3 2022$9,299,000
+6.5%
1,675,5790.0%2.17%
-6.8%
Q2 2022$8,730,000
-36.6%
1,675,5790.0%2.33%
-32.9%
Q1 2022$13,773,000
-44.8%
1,675,5790.0%3.47%
-28.3%
Q4 2021$24,933,000
-21.2%
1,675,5790.0%4.84%
-2.6%
Q3 2021$31,652,000
+1.6%
1,675,5790.0%4.97%
+29.2%
Q2 2021$31,149,000
-18.3%
1,675,5790.0%3.84%
-45.3%
Q1 2021$38,136,000
+4.8%
1,675,5790.0%7.03%
+92.3%
Q4 2020$36,377,000
+116.0%
1,675,5790.0%3.66%
-22.1%
Q3 2020$16,840,000
+29.5%
1,675,5790.0%4.70%
+12.3%
Q2 2020$13,002,000
+13.2%
1,675,579
+48.9%
4.18%
-36.7%
Q1 2020$11,481,000
-7.3%
1,125,5790.0%6.61%
+11.4%
Q4 2019$12,381,000
+21.0%
1,125,5790.0%5.93%
-14.8%
Q3 2019$10,232,000
-20.1%
1,125,5790.0%6.96%
-17.7%
Q2 2019$12,809,000
-0.1%
1,125,5790.0%8.46%
-16.0%
Q1 2019$12,820,000
+26.3%
1,125,579
+0.0%
10.08%
+3.4%
Q4 2018$10,153,0001,125,5769.74%
Other shareholders
SUTRO BIOPHARMA INC shareholders Q4 2023
NameSharesValueWeighting ↓
SV Health Investors, LLC 1,824,542$27,149,00017.55%
Samsara BioCapital, LLC 1,675,579$24,933,0004.84%
AJU IB Investment Co., Ltd. 175,000$2,604,0003.63%
First Light Asset Management, LLC 2,246,588$33,429,0002.39%
Opaleye Management Inc. 680,000$10,118,0002.15%
FRAZIER MANAGEMENT LLC 1,776,479$26,434,0002.04%
Connective Portfolio Management, LLC 35,000$527,0000.93%
Parkman Healthcare Partners LLC 221,219$3,292,0000.73%
SUVRETTA CAPITAL MANAGEMENT, LLC 2,437,795$36,274,0000.70%
Eventide Asset Management 2,708,975$40,310,0000.52%
View complete list of SUTRO BIOPHARMA INC shareholders